A man who received stem cell therapy in a clinical study in Japan for spinal cord injuries has told NHK how he decided to receive the procedure.

DUBLIN--(BUSINESS WIRE)--The "Induced Pluripotent Stem Cell (iPSC) Industry Report - Market Size, Trends, & Forecasts, 2025" report has been added to ResearchAndMarkets.com's offering. Since the ...

In Alzheimer’s and other diseases with complex genetics, differentiating a single induced pluripotent stem cell (iPSC) line from a single endpoint cell may improperly represent the underlying ...

Taiwan’s biotech industry is living its golden days, and LumiSTAR is certainly one of its shining examples. It all started at Oxford University, when LumiSTAR co-founders Yu-Fen Chang, CEO, and ...

Cellino, a biotechnology firm working on autonomous biomanufacturing for personalized regenerative medicines, has signed a strategic collaboration with Karis Bio, a South Korean cell therapy company, ...

Neurodegenerative diseases affect about 15 % of the global population and are on the rise due to aging demographics. Neuroinflammation, driven by the brain’s immune cells known as microglia, is a key ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cellino, a leader in advanced biomanufacturing, today announced that its optical biomanufacturing technology for generating induced pluripotent stem cells (iPSCs) ...

Basic fibroblast growth factor (bFGF) is essential for sustaining pluripotency and enabling lineage-specific differentiation during induced pluripotent stem cell (iPSC) research workflows. In ...

BEACHWOOD, Ohio, Aug. 5, 2025 /PRNewswire/ -- Trailhead Biosystems, Inc. (TrailBio.com), a biotechnology company advancing scalable human cell models derived from induced pluripotent stem cells (iPSCs ...